bpc-157 recommended dosage and cycle length Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Best Way to Take BPC
Description
When administered together, they are typically drawn into the same syringe and injected at the same site chosen for BPC-157
There is a great deal of ongoing research in this area and so recommendations may change
The medications usually fall under the umbrella of muscle relaxants or involuntary movement reducers
The following formula illustrates the relationship: Concentration (mg/mL) = Vial content (mg) Volume of bacteriostatic water added (mL) Illustrative examples: 2 mg vial + 1 mL bacteriostatic water = 2 mg/mL 2 mg vial + 2 mL bacteriostatic water = 1 mg/mL 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL Note that the concentrations in the examples above differ from one another
Most often orally, as a daily capsule one of its practical advantages
The medication also poses little risk of misuse since it must be injected by a medical professional
